Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Melanoma Epidemiology, Diagnosis, and Overdiagnosis in the SEER Database

Description

The speaker introduces a session focused on melanoma diagnosis and the problem of overdiagnosis, with later talks covering clinical assessment and pathology/molecular testing. The presentation reviews how melanoma epidemiology is studied using the NCI SEER database, emphasizing that SEER is a validated, population-based registry that tracks cancer incidence, stage, treatment, and survival, though it does not include basal cell or squamous cell carcinoma. Because newer SEER versions have limited variables, the analysis relies mainly on SEER 17 data, which covers a representative portion of the U.S. population. The talk highlights key epidemiologic patterns: most melanomas occur after age 50, men are diagnosed more often at older ages while younger women have more thin melanomas, trunk is the most common site overall with men more often having trunk and head/neck lesions and women more often lower-limb lesions, and superficial spreading melanoma is the most common subtype overall, while acral melanoma is more prominent in Asian and Black patients. Incidence has risen steadily over time, while mortality has remained relatively stable, supporting concerns about overdiagnosis, especially of thin T1 lesions. A COVID-era dip in diagnoses was mainly due to fewer thin melanomas being detected, but survival remained about 97% and unchanged. The speaker also notes that melanoma survivors have increased risk of second cancers, especially another melanoma, and certain other malignancies such as eye/orbit melanoma, sarcoma, thyroid, salivary gland, and in men kidney and prostate cancer.

View more

Conclusions

  • Melanoma diagnoses have increased over time, but mortality has remained relatively stable, supporting concern that some of the rise reflects overdiagnosis rather than a true increase in lethal disease.
  • Most melanoma cases are diagnosed in older adults, with men tending to present later in life than women.
  • Younger women under 40 appear to have a disproportionately high burden of thin melanomas compared with men, suggesting a major source of increased detection in low-thickness disease.
  • Thin T1 melanomas make up the largest share of diagnosed tumors, while thicker T3 and T4 lesions are much less common.
  • Racial and ethnic groups show different presentation patterns, with Black and some Asian or Pacific Islander patients more likely to present with thicker or acral/nodular melanomas.
  • The trunk is the most common primary site overall, but men are diagnosed more often on the trunk and head/neck, while women are more often diagnosed on the lower limbs.
  • Superficial spreading melanoma remains the most common histologic subtype overall, whereas acral melanoma is relatively uncommon in the general population but more prominent in Black patients.
  • During the COVID era, fewer thin melanomas were diagnosed, yet short-term survival did not appear to change, suggesting delayed detection of low-risk lesions had limited immediate impact on survival.
  • Melanoma survival remains very high and has been stable or slightly improved over time, even as incidence has risen.
  • Melanoma survivors have an elevated risk of second primary cancers, especially another melanoma and certain other malignancies such as eye/orbit melanoma, sarcoma, thyroid, and salivary gland cancers.
  • Nikbakht N, MD, PhD. Current Trends in Melanoma Epidemiology. Emory University School of Medicine.
  • Rohan TZ, Nikbakht N. The risk of developing second primary malignancies in cutaneous melanoma survivors.#10.1016/j.jaad.2024.11.059
  • SEER Reported Long-Term Trends in US Age-Adjusted Mortality Rates, 1975-2022.#10.1787/520004880758
  • Incidence and Death Rates of Skin Melanoma, 1992-2023. https://seer.cancer.gov/statfacts/html/melan.html
  • Characteristics of Cutaneous Melanoma Patients in the SEER17 Database, 2000-2022.
  • Histological Subtypes for Cutaneous Melanomas in the SEER Database, 2010–2021.